DexCare, a Seattle, WA-based provider of a patient demand and care access platform, raised $75M in Series C funding.
The round, which brought the total amount to $146M, was led by ICONIQ Growth with participation from participation existing partners Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures.
The company intends to use the funds to advance its platform, which extends limited health-system capacity to serve patients faster and to manage the supply and demand of digital-care access.
Led by CEO Derek Streat, DexCare is a care-access platform to manage the logistics of digital-care delivery. The platform enables healthcare systems to forecast and predict demand and manage how and where care is merchandized to consumers – throughout the digital ecosystem. By simplifying large, complex, and legacy datasets, the company resolves workforce constraints, and provides the levers to coordinate scheduling, across services and modalities, to optimize capacity and operational costs.
Today, DexCare serves more than 57 million patients across 50 states, and partners with leading U.S. health systems, including Kaiser Permanente, Providence, and Community Health Network.
FinSMEs
21/06/2023